Atlas Trials

Chemoembolization for Hepatocellular Carcinoma

Clinical trial NCT02821533 · TERMINATED

Trial details

NCT number
NCT02821533
Sponsor
Chinese University of Hong Kong
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2012-02-01
Primary completion
2017-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.